piperacillin has been researched along with Cystitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Dahmoshi, HOM; Ben Amara, I; Eleroui, M; Mukheef, SA | 1 |
| Doi, Y; Qureshi, ZA | 1 |
| Chen, YM; Huang, CC; Kuo, CC; Tsai, CH; Yang, FJ | 1 |
| Andreoni, G; Angela, GC; Bramato, C; Capra, E; Cignolo, G; Di Nola, F; Musso, E; Pizzo, L; Salassa, B; Soranzo, ML; Spezia, C | 1 |
| Endo, K; Imamura, K; Kumasaka, Y; Masaki, N; Matsuhashi, A; Nakahata, H; Narita, S; Sasaki, K; Takebe, K; Tamura, T | 1 |
| Alpert, SE; Marx, CM | 1 |
| Hirose, T; Kumamoto, Y; Nishimura, M; Ohya, S; Shibuya, A; Tsukamoto, T | 1 |
| Honore, P; Joshi, SK; Mikusa, JP; Weaver, B | 1 |
1 review(s) available for piperacillin and Cystitis
| Article | Year |
|---|---|
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States | 2014 |
7 other study(ies) available for piperacillin and Cystitis
| Article | Year |
|---|---|
Prevalence of Some Group A Beta-Lactamase Genes among Uropathogenic Escherichia coli isolated from Women with Cystitis.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cystitis; Escherichia coli Infections; Female; Humans; Piperacillin; Prevalence; Uropathogenic Escherichia coli | 2022 |
Bubbles in the urinary bladder.
Topics: Anti-Bacterial Agents; Cystitis; Female; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Shock, Septic; Tazobactam; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Diseases | 2012 |
[Piperacillin: microbiological and clinical studies].
Topics: Acinetobacter; Adolescent; Adult; Aged; Brucellosis; Child; Cystitis; Escherichia coli; Female; Humans; In Vitro Techniques; Klebsiella Infections; Male; Middle Aged; Penicillins; Piperacillin; Proteus; Respiratory Tract Infections; Staphylococcus aureus | 1983 |
[Laboratory and clinical studies on cefsulodin (author's transl)].
Topics: Adult; Aged; Cefsulodin; Cephalosporins; Cystitis; Drug Evaluation; Female; Gentamicins; Humans; Male; Middle Aged; Penicillin Resistance; Penicillins; Piperacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
Ticarcillin-induced cystitis. Cross-reactivity with related penicillins.
Topics: Carbenicillin; Child; Child, Preschool; Cross Reactions; Cystic Fibrosis; Cystitis; Hematuria; Humans; Male; Penicillins; Piperacillin; Ticarcillin | 1984 |
[Significance of the combined treatment with isepamicin and piperacillin in an in vitro model for complicated cystitis operated by automatic simulator apparatus for urinary concentration].
Topics: Computer Simulation; Cystitis; Drug Therapy, Combination; Gentamicins; In Vitro Techniques; Piperacillin | 1992 |
Morphine and ABT-594 (a nicotinic acetylcholine agonist) exert centrally mediated antinociception in the rat cyclophosphamide cystitis model of visceral pain.
Topics: Analgesics; Animals; Azetidines; Behavior, Animal; Brain; Chlorisondamine; Cyclophosphamide; Cystitis; Disease Models, Animal; Male; Mecamylamine; Morphine; Naloxone; Narcotic Antagonists; Nicotinic Antagonists; Pain; Pyridines; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Viscera | 2008 |